Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Frailty × Ascorbic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 8 Multiple Myeloma 6 Neoplasms, Plasma Cell 4 Prostatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Sarcoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Diseases 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Myeloproliferative Disorders 1 Mucositis 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphoid 1 Inflammation 1

Interventions

peflavit 1 microcrystalline cellulose 1 fisetin 1 epigallocatechin gallate 1 cabozantinib 1 Temozolomide 1 Quercetin 1 Protons 1 Photons 1 Flavonoids 1 Dasatinib 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068543 2026-03-06

ReFOCUS2

University of Rochester

Phase 2 Recruiting

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡